Toh LL – cytomed
Menu
Home
About
About Us
Our Team
Publications
Briefs
Platform
CAR-γδ T Cell
iPSC-γδ NKT Cell
Pipeline
Manufacturer
Investor
Investor Relations
Financial Reports
Contact Us
Shareholder Benefits
Make An Appointment
Generation of “Off-the-Shelf” Natural Killer Cells from Peripheral Blood Cell-Derived Induced Pluripotent Stem Cells
